by Eric Christianson | May 31, 2026 | Endocrine Medication and Disease State Clinical Pearls
Weight loss medications can differ substantially in efficacy, adverse effect profiles, and monitoring considerations, making patient-specific counseling essential. In this blog post, I share common practice pearls for weight loss medications. GLP-1 Type Agents Slow...
by Eric Christianson | May 10, 2026 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Seasonal affective disorder (SAD) presents a unique opportunity in psychiatric prescribing because, unlike many other mood disorders, the timing of symptoms is often predictable. Patients typically experience depressive symptoms during the fall and winter months, with...
by Eric Christianson | Sep 24, 2025 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
When working with patients who have a seizure disorder, it’s critical for pharmacists to remember which medications can lower the seizure threshold. Even in patients without epilepsy, some drugs can increase seizure risk, especially at high doses, in overdose...
by Eric Christianson | Jul 7, 2024 | Psychiatry and Addiction Medicine Case Studies
JS is a 45 year-old male who has been taking bupropion SR 150 mg twice daily for about 4 weeks. He has been taking it for depression. He reports that depressive symptoms have started to improve but he does notice that he has a harder time getting to sleep and staying...
by Eric Christianson | Jun 9, 2024 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Bupropion (Wellbutrin) is an antidepressant that is most commonly used as an alternative (or sometimes in combination) to SSRIs. In this post, I will share my most important bupropion clinical pearls as well as some things that may show up on your board exam! Seizure...
